An essay on the shaking palsy. 1817, J. Neuropsychiatry Clin. Neurosci, vol.14, pp.223-236, 2002. ,
Incidence of parkinson's disease: Variation by age, gender, and race/ethnicity, Am. J. Epidemiol, vol.157, pp.1015-1022, 2003. ,
Epidemiology of parkinson's disease, Lancet Neurol, vol.5, pp.525-535, 2006. ,
Parkinson's disease: Mechanisms and models, Neuron, vol.39, pp.889-909, 2003. ,
Molecular pathology of lewy body diseases, Int. J. Mol. Sci, vol.10, pp.724-745, 2009. ,
Immunohistochemical analyses of the postmortem human brains from patients with parkinson's disease with anti-tyrosine hydroxylase antibodies, Biog. Amines, vol.23, pp.1-7, 2009. ,
Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci, vol.8, pp.2804-2815, 1988. ,
Alpha-synuclein in filamentous inclusions of lewy bodies from parkinson's disease and dementia with lewy bodies, Proc. Natl. Acad. Sci, vol.95, pp.6469-6473, 1998. ,
Filamentous alpha-synuclein inclusions link multiple system atrophy with parkinson's disease and dementia with lewy bodies, Neurosci. Lett, pp.205-208, 1998. ,
Propagation of alpha-synuclein strains within human reconstructed neuronal network, Stem Cell Rep, vol.12, pp.230-244, 2019. ,
Structural and functional properties of prefibrillar alpha-synuclein oligomers, Sci. Rep, 2016. ,
Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration, Nature, vol.522, pp.340-344, 2015. ,
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset parkinson disease, Nat. Med, vol.4, pp.1318-1320, 1998. ,
In vivo demonstration that alpha-synuclein oligomers are toxic, Proc. Natl. Acad. Sci, vol.108, pp.4194-4199, 2011. ,
Two conformationally distinct alpha-synuclein oligomers share common epitopes and the ability to impair long-term potentiation, Plos One, vol.14, 2019. ,
Early stages of aggregation of engineered alpha-synuclein monomers and oligomers in solution, Sci. Rep, vol.9, 1734. ,
Direct observation of abeta amyloid fibril growth and inhibition, J. Mol. Biol, vol.344, pp.757-767, 2004. ,
Alpha-synuclein disrupts stress signaling by inhibiting polo-like kinase cdc5/plk2, Proc. Natl. Acad. Sci, vol.109, pp.16119-16124, 2012. ,
The many faces of alpha-synuclein: From structure and toxicity to therapeutic target, Nat. Rev. Neurosci, vol.14, pp.38-48, 2013. ,
Alpha-synuclein assemblies sequester neuronal alpha3-na+/k+-atpase and impair na+ gradient, Embo J, vol.34, pp.2408-2423, 2015. ,
Import and export of misfolded alpha-synuclein, Front. Neurosci, vol.12, 2018. ,
Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3, p.353, 2016. ,
Investigation of endocytic pathways for the internalization of exosome-associated oligomeric alpha-synuclein, Front. Neurosci, vol.11, p.172, 2017. ,
Alpha-synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins, Proc. Natl. Acad. Sci, vol.98, pp.9110-9115, 2001. ,
Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins, J. Biol. Chem, vol.276, pp.41958-41962, 2001. ,
The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in parkinson's disease, Neuron, vol.37, pp.583-595, 2003. ,
Fabp3 protein promotes alpha-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity, J. Biol. Chem, vol.289, pp.18957-18965, 2014. ,
Inhibition of mptp-induced alpha-synuclein oligomerization by fatty acid-binding protein 3 ligand in mptp-treated mice, Neuropharmacology, vol.150, pp.164-174, 2019. ,
Development of fabp3 ligands that inhibit arachidonic acid-induced alpha-synuclein oligomerization, Brain Res, vol.1707, pp.190-197, 2019. ,
Targeting programmed cell death in neurodegenerative diseases, Nat. Rev. Neurosci, vol.4, pp.365-375, 2003. ,
Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in pc12d cells, J. Neural Transm, vol.116, pp.1571-1578, 2009. ,
Pathophysiology of synuclein aggregation in lewy body disease, Mech. Ageing Dev, vol.127, pp.188-202, 2006. ,
Mitochondria and neurodegeneration, Biosci. Rep, vol.27, pp.87-104, 2007. ,
Mitochondria modulate programmed neuritic retraction, Proc. Natl. Acad. Sci, vol.116, pp.650-659, 2019. ,
4-hydroxy-2-nonenal (4-hne) staining by anti-hne antibody, Methods Mol. Biol, vol.196, pp.31-34, 2002. ,
Dopamine transporter: Involvement in selective dopaminergic neurotoxicity and degeneration, J. Neural Transm, vol.111, pp.1267-1286, 2004. ,
Functional characterization of fabp3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies, Hum. Mol. Genet, vol.23, pp.6495-6511, 2014. ,
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia, Arch. Gen. Psychiatry, vol.57, pp.65-73, 2000. ,
Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene, Circ. Res, vol.85, pp.329-337, 1999. ,
Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization, Faseb J, vol.13, pp.805-812, 1999. ,
Dopamine or biopterin deficiency potentiates phosphorylation at (40)ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system, Biochem. Biophys. Res. Commun, vol.465, pp.53-58, 2015. ,
Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images, Cytom. Part. A J. Int. Soc. Anal. Cytol, vol.58, pp.167-176, 2004. ,
Dendritic organization in the neurons of the visual and motor cortices of the cat, J. Anat, vol.87, pp.387-406, 1953. ,
Neuronal morphometry directly from bitmap images, Nat. Methods, vol.11, pp.982-984, 2014. ,
Als-implicated protein tdp-43 sustains levels of stmn2, a mediator of motor neuron growth and repair, Nat. Neurosci, vol.22, pp.167-179, 2019. ,